Core Viewpoint - The company, Beirui Gene, is seeking a credit facility of 40 million yuan for its wholly-owned subsidiary, Hangzhou Beirui, to support its operations and ensure stable development [1][2]. Financial Overview - As of March, Hangzhou Beirui reported total assets of 1.106 billion yuan, total liabilities of 266 million yuan, and net assets of 840 million yuan [2]. - In the first quarter, Hangzhou Beirui's unaudited revenue and net profit were 90.06 million yuan and 4.49 million yuan, respectively [2]. - The total amount of external guarantees provided by Beirui Gene and its subsidiaries is 357 million yuan, which is 21.26% of the latest audited net assets [2]. Performance Challenges - Beirui Gene has faced continuous performance pressure since 2021, with revenues declining from 1.422 billion yuan in 2021 to an expected 1.078 billion yuan in 2024, and net profits turning negative [4]. - The company anticipates a net loss of 22 million to 33 million yuan in the first half of 2025, compared to a profit of 9.26 million yuan in the same period last year [4]. Market Position and Future Plans - The company focuses on the reproductive health sector, with significant commercial success in prenatal testing, while the prenatal and newborn markets are still in the early stages [5]. - Beirui Gene plans to leverage artificial intelligence and its advanced sequencing technology to expand into more complex genetic testing services and provide direct health services to consumers [5].

Group 1 - The 11th China (Shanghai) International Technology Import and Export Fair will be held from June 11 to 13, 2025, with the theme "Open Cooperation: Empowering New Quality Productivity and Sustainable Development" [1] - The fair will feature a total exhibition area of 35,000 square meters, including one theme pavilion, one provincial exhibition area, and four specialized technology exhibition areas [1] - Nearly 1,000 participating companies will showcase new products and technologies, with 14 companies and institutions debuting innovations, including 7 global or national premieres [1] Group 2 - The fair will highlight key technological breakthroughs from the Yangtze River Delta region and showcase innovations from the Guangdong-Hong Kong-Macao Greater Bay Area, including interactive robots and gene testing equipment [2] - Strategic emerging industries will be prominently featured, including AI solutions across various sectors, such as AI brain-computer interface platforms and AI drones [2] - Notable innovations include the world's first polar fixed-wing aircraft and a new drug for complete hepatitis B cure, showcasing significant advancements in autonomous innovation [2] Group 3 - International collaboration will be emphasized, with 46 companies from nearly 20 countries and regions presenting leading technology projects, including contributions from Glasgow and the United Nations Industrial Development Organization [3] - Since its inception in 2013, the fair has attracted over 9,500 companies from more than 30 countries and regions, facilitating over 500 intended transaction projects in recent editions [3] - Shanghai's technology import and export contract amount has seen an average annual growth of 8.6% since the 14th Five-Year Plan, reaching a historical high of $21.33 billion in 2024, a 17.7% increase year-on-year [3]